Inventor · disambiguated record
Creg J. Workman
Also filed as: WORKMAN CREG · WORKMAN CREG J
7 granted patents·6 pending applications·88 citations·filing 2004–2023
85Inventor score
Files withUNIV JOHNS HOPKINS6ST JUDE CHILDRENS RES HOSPITAL2ST JUDE CHILDREN’S RES HOSPITAL2PARDOLL DREW M1ST JUDE S CHILDREN S RES HOSPITAL INC1
Top patents by PatentIndex Score
13 records- 0196US9005629B2Method for treating cancer with an antibody to CD223 proteinUNIV JOHNS HOPKINS·Filed 2012·Granted Apr 14, 2015·42 cites·4 claims
- 0293US8551481B2Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibodyPARDOLL DREW M·Filed 2009·Granted Oct 8, 2013·41 cites·6 claims
- 0384US2024174747A1T cell regulationUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 0479US10787513B2Methods for treatment comprising an antibody that binds CD223 proteinUNIV JOHNS HOPKINS·Filed 2015·Granted Sep 29, 2020·1 cites·25 claims
- 0574US2021230275A1T cell regulationUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 0673US9217135B2T effector cells modulated via interleukin 35 and methods of culturing sameST JUDE CHILDRENS RES HOSPITAL·Filed 2014·Granted Dec 22, 2015·1 cites·4 claims
- 0772US10934354B2Methods of increasing T cell immune response in the treatment of cancerUNIV JOHNS HOPKINS·Filed 2018·Granted Mar 2, 2021·0 cites·20 claims
- 0871US8784807B2Method of inhibiting regulatory T-cell activity by administering an antibody that inhibits interleukin 35VIGNALI DARIO·Filed 2007·Granted Jul 22, 2014·2 cites·4 claims
- 0970US9518113B2Monoclonal antibodies to interleukin 35 and methods of use thereof to inhibit regulatory T cell functionST JUDE CHILDREN'S RES HOSPITAL·Filed 2015·Granted Dec 13, 2016·1 cites·23 claims
- 1068US2014127226A1T Cell RegulationST JUDE S CHILDREN S RES HOSPITAL INC·Filed 2013·Application pending·0 cites
- 1164US2006240024A1T cell regulationST JUDE CHILDRENS RES HOSPITAL·Filed 2004·Application pending·0 cites
- 1256US2017073410A1Monoclonal antibodies to interleukin 35 and methods of use thereof to inhibit regulatory t cell functionST JUDE CHILDREN'S RES HOSPITAL·Filed 2016·Application pending·0 cites
- 1340US2019194324A1THERAPEUTIC USES OF LAG3 THE (alpha)-SYNUCLEIN TRANSMISSION RECEPTORUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Creg J. Workman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →